GP1025C Advanced Ovarian Cancer patients in the US using PARP inhibitor

We currently have a new study in the US about Ovarian Cancer.

The study will involve a 60 min interview for which participants will be compensated with $150 USD and with additional $75 USD for providing a proof of diagnosis to be eligible to participate. There is no medical treatment being provided as part of this study; it is completely non-interventional.

We were wondering if you could collaborate with us by sharing this study information and our contact with the members of your association, so if anyone is interested, they could reach out to us directly.

We would be happy to provide any other information or schedule a phone call if you have any questions!

Please contact

Join this Study
Are you already a member of Global Patients?